test tubes containing pink fuid


Exploiting polymer-based delivery systems for anti-inflammatory indirubin-based 6BIGOE derivatives in in vitro and in vivo proof-of-principle studies
test tubes containing pink fuid

Indirubin-derived 6BIGOE potently inhibits pro-inflammatory interleukin(IL)-1β and prostaglandin (PG)E2 release in human monocytes with unknown mode of action, which shall be revealed. Because of inappropriate physicochemical properties, 6BIGOE shall be encapsulated into nanoparticles based on polymers of lactic and glycolic acid, stabilized by stealth polymers and targeted with e.g. Arg-Gly-Asp (RGD) ligands. Bioactivities will be tested in primary human monocytes/macrophages and their co-cultures with endothelial cells as well as in the HET-CAV (hen’s egg test – chick area vasculosa).

graphical abstract C02 Image: D. Fischer

Principle Investigators:

Prof. Dr. Dagmar Fischer

Department of Chemistry and Pharmacy
Division of Pharmaceutical Technology
Friedrich-Alexander-Universität Erlangen-Nürnberg
Cauerstr. 6 (Haus 4)
91058 Erlangen
Phone: +49 9131 85-29552

Prof. Dr. Oliver Werz

Institute of Pharmacy (IP)
Friedrich Schiller University of Jena
Philosophenweg 14
07743 Jena
Phone: +49 3641 9-49801


Christian Grune
Institute of Pharmacy (IP)
Otto-Schott-Straße 41, 07745 Jena
Phone: +49 3641 9-49925

Anna Czapka
Institute of Pharmacy (IP)
Philosophenweg 14, 07743 Jena
Phone: +49 3641 9-49616


Share this page
Friedrich Schiller University on social media:
Studying amid excellence:
  • Logo of the "Total E-Quality" initiative
  • Logo of the best practice club "Family in Higher Education Institutions"
  • Logo of the "Partner University of High Performance Sports" project
  • Logo of quality of German Accreditation Council - system accredited
Top of the page